Posts for Ticker ‘BAY’

Europe Markets 4/24/2008 (BHP)(BCS)(SAP)(ALU)(STM)

Markets in Europe were off at 6.35 AM New York time.

The FTSE was down 1.7% to 5,977. Barclays (BCS) was down 2.4% to 445.  BHP Billiton (BHP) was off 5% to 1831.

The DAXX dropped .9% to 6,733. Bayer was up 2.6% to 53.36. SAP (SAP) was down 1.7% to 32.11.

The CAC 40 was off 1.2% to 4,887. Alcatel-Lucent (ALU) was down 1.6% to 3.99. ST Micro (STM) was down 2.1% to 6.94.

Data from Reuters

Douglas A. McIntyre

Europe Markets 2/28/2008 (VOD)(BAY)(AXA)(SI)

Stocks fell in Europe at 6.55 AM New York time.

The FTSE was off .8% to 6,033. Whitbread rose 7.1% to 1313. Vodafone (VOD) fell 1.1% to 162.4.

The DAXX dropped .8% to 6,941. Bayer (BAY) fell 3.4% to 52.26. Siemens (SI) fell 2.3% to 89.98.

The CAC 40 sold off .8% to 4,929. AXA (AXA) fell 2.5% to 23.25. EADS dropped 2.9% to 18.25.

Data from Reuters

Douglas A. McIntyre

Europe Markets 1/8/2008

Markets in Europe were modestly higher at 6.35 AM New York time.

The FTSE rose .5% to 6,370. Barclays (BCS) fell 2.2% to 461.25. BT (BT) rose 1.9% to 289.

The DAXX was up .6% to $7,863. Bayer (BAY) was up 2.7% to 65.20. Deutsche Telekom (DT) was up 2.2% to 15.77.

The CAC 40 moved up .9% to 5,499. France Telecom (FTE) was up 2.5% to 25.83. Air France was down 3.6% to 21.34.

Data from Reuters

Douglas A. McIntyre

Bayer’s Death Drug

Add to the list of reasons not to have open heart surgery the potential use of Bayer’s (BAY) Trasylol to control bleeding. According to The Wall Street Journal  "two studies published in 2006 suggested the drug doubled the risk of kidney failure/" The FDA is reviewing the drug due to the kidney issue and because" two additional studies have suggested the drug also could increase the risk of death."

The FDA has a "black box" warning on the Trasylol label. but the studies do raise that question of why the drug is on the market at all.

Maybe someone should look into this.

Douglas A. McIntyre

Europe Markets 8/21/2007

Markets in Europe were slightly down at 6.40 AM New York time.

The FTSE fell .3% to 6,058. Barclays (BCS) fell 1.6% to 624.5. Vodafone (VOD) rose .4% to 155.9.

The DAXX dropped .4% to 7,379. Bayer (BAY) rose 4.6% to 57.17. DeutscheBank (DB) fell 1.6% to 91.98.

The CAC 40 was down .3% to 5,386. BNP Paribas was off 1.7% to 76.95.

Data from Reuters

Douglas A. McIntyre

Europe Markets 8/9/2007

Markets in Europe were down sharply at 6.10 AM New York time.

The FTSE fell .9% to 6,338. Barclays (BCS) was down 3% to 691. BP (BP) was down 2.2% to 545.5. BT (BT) was off 1.9% to 312.25.

The DAXX was off 1.2% to 7,512. Bayer (BAY) was down 2.5% to 52.88. DB (DB) was down 2.4% to 100.22. DT (DT) was up 1.2% to 13.23. SAP (SAP) was up 1.3% to 40.54.

The CAC 40 fell 1.6% to 5,658. Alcatel-Lucent rose 1.9% to 8.61. AXA (AXA) fell 3.3% to 29.09. France Telecom (FTE) fell 1.1% to 20.66.

Data from Reuters.

Douglas A. McIntyre

Europe Markets 8/8/2007

Markets in Europe were broadly higher at 6.40 AM New York time.

The FTSE rose 8% to 6,349. BHP Billiton (BHP) was up 1.8% to 1388. Vodafone (VOD) rose .3% to 158.8.

The DAXX rose.6% to 7,557. Bayer (BAY) rose 3.8% to 53.19. Daimler (DCX) fell 1.9% to 62.88. Siemens (SI) rose 1.2% to 94.42.

The CAC 40 was up .9% to 5,675. Alcatel-Lucent (ALU) was up 1.5% to 8.29. AXA (AXA) was up 2.7% to 29.82.

Data from Reuters

Douglas A. McIntyre

Europe Markets 8/2/2007

Markets in Europe were higher at 6.50 AM New York time.

The FTSE rose .7% to 6,295. BP (BP) was down 1.4% to 565.5. BT (BT) was up 1.9% to 315.75. GSK (GSK) was up 1.4% to 1273.

The DAXX rose 1.1% to 7,553. Bayer (BAY) rose 2% to 52.66. DeutscheBank (DB) rose 2% to 100.76. Deutsche Telekom (DT) rose 1.9% to 12.76.

The CAC 40 rose .6% to 5,688. AXA (AXA) rose 1.8% to 28.64. France Telecom (FTE) rose 2.9% to 20.23.

Data from Reuters

Douglas A. McIntyre

Europe Markets 7/30/2007

Markets in Europe were up very modestly at 6.20 AM New York time.

The FTSE rose .2% to 6,223. Barclays (BCS) was down 1.1% to 674.5. Prudential (PUK) was down 1.6% to 653.5. Vodafone (VOD) was down 1.1% to 149.6.

The DAXX was off .1% to 7,459. Bayer (BAY) was up 1.2% to 50.92. DeutscheBank (DB) was off 1.4% to 96.48.

The CAC 40 was up .2% to 5,657. Alcatel-Lucent (ALU)  was up 1.1% to 9.62. Suez (SZE) was down 1.6% to 37.58.

Data from Reuters.

Douglas A. McIntyre

Europe Markets 7/24/2007

Markets in Europe were lower at 5.55 AM New York time.

The FTSE was off .3% to 5,602. Barclays (BCS) was up 2.3% to 752. BP (BP) was up .2% to 603. Vodafone (VOD) was up .1% to 160.7.

The DAXX fell .4% to 7,910. Bayer (BAY) was off 1.2% to 54.52. Deutsche Telekom (DT) was off .5% to 13.15. SAP (SAP) was off .3% to 41.02.

The CAC 40 fell .3% to 5,993. AXA (AXA) was down 1.3% to 31.13.

Data from Reuters

Douglas A. McIntyre

Europe Markets 7/4/2007

Europe markets were up modestly at 7 AM New York time.

The FTSE rose .3% to 6,656. Barclays (BCS) rose 1.5% to 706. Vodafone (VOD) fell .4% to 165.1.

The DAXX rose .4% to 8,080. Bayer (BAY) rose 1.4% to 5,718. SAP (SAP) rose .7% to 37.45.

The CAC 40 rose .3% to 6,090. France Telecom (FTE) rose .6% to 20.4.

Data from Reuters

Douglas A. McIntyre

Pre-Market Stock News (June 27, 2007)

(ANDW) Andrew Corp being acquired for $15.00 per share.
(APOG) Apogee Enterprises $0.34 EPS vs $0.23e; unsure if comparable.
(AUTH) AuthenTec priced its 7.5M share IPO at the top of the $9.00 to $11.00 range for 7.5 million shares.
(BAY) Bayer AG and Onyx submit supplemental new drug application for Nexavar to treat liver cancer.
(CTV) Commscope raised guidance.
(GTRC) Guitar Center being acquired by Bain Capital for $63.00 per share.
(ISTA) ISTA Pharmaceuticals will raise $36.75 million in private placement.
(JSDA) Jones Soda announced exclusive formula use pact in Japan.
(KVHI) KVH Industries announced that Monaco Coach will add the KVH TracVision R-series of mobile satellite TV systems to their new 2008 vehicles.
(NKE) Nike $0.86 EPS vs $0.86e.
(NUVO) Nuvelo lost Bayer as R&D partner in stroke trials.
(ORCL) Oracle $0.37 EPS vs $0.35e.
(PAYX) Paychex reports earnings after close: $0.36 EPS and $496.3M revenue expected.
(RYAAY) Ryanair blocked by EU in bid to buy Aer Lingus.
(SCOR) comScore priced its 5.3 million share IPO at $16.50 per share.
(SMSC) $0.29 EPS vs $0.25e.
(SQNM) Sequenom announced it will develop HPVtest and other diagnostics with SensiGEn LLC.
(TASR) Taser announced a suit in St. Louis against the company was voluntarily dismissed.
(TOPP) Topps Co. said Upper Deck has initiated a $10.75 per share tender.
(YMI) YM BioSciences received FDA Clearance for an IND for its fentanyl-based pain product.
(YUM) Yum! Brands trades ex-split to reflect a 2-1 stock split.

Jon C. Ogg
June 27, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Nuvelo Loses Bayer as Development Partner in Stroke Treatment (NUVO, BAY)

Nuvelo, Inc. (NUVO-NASDAQ) dropped the bomb today with the announcement that it will resume development of alfimeprase, its lead investigational product candidate for the potential treatment of multiple blood clot-related disorders such as acute ischemic stroke, catheter occlusion (CO) and acute peripheral arterial occlusion (PAO).

In addition, Nuvelo and Bayer HealthCare have agreed to terminate their collaboration.  Nuvelo has agreed to waive Bayer’s obligation to provide Nuvelo twelve-months’ notice of termination in consideration of Bayer’s agreement to pay Nuvelo a lump sum of $15 million. Nuvelo has also granted Bayer the one-time option to reacquire rights to alfimeprase upon the initiation of a pivotal stroke trial, on the same terms as the original agreement with the addition of a $15 million option exercise payment from Bayer.

Nuvelo (NUVO) shares are trading down 19% at $2.70 in after-hours trading.  Losing a larger partner is almost never considered a good thing on Wall Street.

Read More »

Pre-Market Stock News (June 19, 2007)

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.
(BAY) Bayer raised guidance on Schering integration.
(BMY) Bristol-Myers: FDA Grants Priority Review for Bristol-Myers Squibb’s Investigational Oncology Treatment Ixabepilone.
(BTU) Peabody Energy was named Cramer’s favorite pick in the coal sector.
(CLRK) Color Kinetics trading up 11% at $33.00+ on $34 buyout from Philips Electronics.
(CPKI) California Pizza Kitchen trades ex-split today to reflect a 3-2 stock Split.
(CUB) Cubic received a $468 million contract to give mission support to Army readiness training center.
(DAL) Delta is considering a 125 Boeing order for Dreamliners.
(DJ) Dow Jones may get a bid from billionaire Ron Burkle.
(EXPE) Expedia buying back $3.5 Billion in stock.
(FDS) FactSet $0.52 EPS vs $0.51 estimate.
(GE) GE buying controlling stake in natural gas pipeline Regency for $603 million.
(INO) Inovio Biomedical’s selective electrochemical tumor ablation therapy demonstrated safety, tolerability, and complete responses in breast cancer study.
(LNET) LodgeNet noted positively by Cramer on Mad Money.
(MRO) Marathon Oil trades ex-split today to reflect a 2-1 stock split.
(PRGS) Progress Software $0.45 EPS vs $0.41e.
(STR) Questar trades ex-split to reflect a 2-1 stock split.
(SGMO) Sangamo BioScience reached milestones in agriculture collaboration with Dow AgroSciences.
(SIRI) SIRIUS signed Volkswagen as standard equipment on all Touareg, New Beetle, New Beetle Convertible, GTI, and GLI sales for the 2008 models.
(TASR) TASER announced foreign order for 1,375 devices.
(TSN) Tyson making product announcementthis morning.
(YHOO) Yahoo! trading up 8% after Semel stepped down as CEO and co-founder Jerry Yang came back as CEO; Semel remaining non-executive Chairman.
(ZGEN) ZymoGenetics entered a global collaboration pact with Bayer for development and commercialization of recombinant human thrombin.

Jon C. Ogg
June 19, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Earlybird Analyst Calls (June 6, 2007)

AGN started as Buy at Jefferies.
AW started as Outperform at Credit Suisse.
BAY started as Overweight at JPMorgan.
CACH cut to Neutral at Merriman Curhan Ford.
CIEN started as Outperform at Piper Jaffray.
CPNO started as Outperform at Morgan Keegan.
EPD started as Outperform at Morgan Keegan.
EPE started as market perform at Morgan Keegan.
ETE started as Outperform at Morgan Keegan.
ETP started as Outperform at Morgan Keegan.
GILD cut to Neutral at Credit Suisse.
IMA started as Buy at Stifel Nicolaus.
JCI raised to Outperform at Credit Suisse.
KMP started as Outperform at Morgan Keegan.
KSE raised to Neutral at Credit Suisse.
LOOP started as Buy at Sun Trust Robinson Humphrey.
MNT started as Buy at Jefferies.
NTEC started as Outperform at Rodman & Renshaw.
ORBC started as Outperform at CIBC.
RSG started as Outperform at Credit Suisse.
SINT cut to Hold at Stifel Nicolaus.
TEVA raised to Outperform at Credit Suisse.
VLTR cut to Sector Perform at CIBC.
VRUS started as Buy at B of A.
WMI started as Outperform at Credit Suisse.

Jon C. Ogg
June 6, 2007